ReP USP - Resultado da busca

Artigo de periodico
Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives (2016)
Ribeiro, Ronaldo A.; Wanderley, Carlos W. S.; Wong, Deysi V. T.; Mota, José Maurício S. C.; Leite, Caio A. V. G.; Souza, Marcellus H. L. P.; Cunha, Fernando de Queiroz; Lima Junior, Roberto César P.
Source: Cancer Chemotherapy and Pharmacology. Unidade: FMRP
Subjects: ENTEROPATIAS, ANTINEOPLÁSICOS, CITOCINAS, RECEPTORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, Ronaldo A. et al. Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives. Cancer Chemotherapy and Pharmacology, v. 78, n. 5, p. 881-893, 2016Tradução . . Disponível em: https://doi.org/10.1007/s00280-016-3139-y. Acesso em: 01 nov. 2024.
APA
Ribeiro, R. A., Wanderley, C. W. S., Wong, D. V. T., Mota, J. M. S. C., Leite, C. A. V. G., Souza, M. H. L. P., et al. (2016). Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives. Cancer Chemotherapy and Pharmacology, 78( 5), 881-893. doi:10.1007/s00280-016-3139-y
NLM
Ribeiro RA, Wanderley CWS, Wong DVT, Mota JMSC, Leite CAVG, Souza MHLP, Cunha F de Q, Lima Junior RCP. Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives [Internet]. Cancer Chemotherapy and Pharmacology. 2016 ; 78( 5): 881-893.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1007/s00280-016-3139-y
Vancouver
Ribeiro RA, Wanderley CWS, Wong DVT, Mota JMSC, Leite CAVG, Souza MHLP, Cunha F de Q, Lima Junior RCP. Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives [Internet]. Cancer Chemotherapy and Pharmacology. 2016 ; 78( 5): 881-893.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1007/s00280-016-3139-y
Trabalho de evento-resumo periodico
Usefulness of broad-range PCR in the etiologic diagnosis of sepsis (2013)
Gozzi, Aline; Lobo, Romulo R.; Mota, José Maurício S. C.; Pazin Filho, Antonio; Fonseca, Benedito Antonio Lopes da; Borges, Marcos de Carvalho
Source: Critical Care. Conference titles: International Sepsis Forum. Unidade: FMRP
Subjects: SEPSE, DIAGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOZZI, Aline et al. Usefulness of broad-range PCR in the etiologic diagnosis of sepsis. Critical Care. Houten: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1186/cc12942. Acesso em: 01 nov. 2024. , 2013
APA
Gozzi, A., Lobo, R. R., Mota, J. M. S. C., Pazin Filho, A., Fonseca, B. A. L. da, & Borges, M. de C. (2013). Usefulness of broad-range PCR in the etiologic diagnosis of sepsis. Critical Care. Houten: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1186/cc12942
NLM
Gozzi A, Lobo RR, Mota JMSC, Pazin Filho A, Fonseca BAL da, Borges M de C. Usefulness of broad-range PCR in the etiologic diagnosis of sepsis [Internet]. Critical Care. 2013 ; 17[citado 2024 nov. 01 ] Available from: https://doi.org/10.1186/cc12942
Vancouver
Gozzi A, Lobo RR, Mota JMSC, Pazin Filho A, Fonseca BAL da, Borges M de C. Usefulness of broad-range PCR in the etiologic diagnosis of sepsis [Internet]. Critical Care. 2013 ; 17[citado 2024 nov. 01 ] Available from: https://doi.org/10.1186/cc12942
Artigo de periodico
Inflammatory intestinal damage induced by 5-fluorouracil requires IL-4 (2013)
Soares, Pedro M. G.; Mota, José Maurício S. C.; Souza, Emmanuel P.; Justino, Priscilla F. C.; Franco, Alvaro X.; Cunha, Fernando de Queiroz; Ribeiro, Ronaldo A.; Souza, Marcellus H. L. P.
Source: Cytokine. Unidade: FMRP
Subjects: MUCOSA INTESTINAL, INFLAMAÇÃO, INTERLEUCINA 4, ANTIMETABÓLITOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOARES, Pedro M. G. et al. Inflammatory intestinal damage induced by 5-fluorouracil requires IL-4. Cytokine, v. 61, n. 1, p. 46-49, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.cyto.2012.10.003. Acesso em: 01 nov. 2024.
APA
Soares, P. M. G., Mota, J. M. S. C., Souza, E. P., Justino, P. F. C., Franco, A. X., Cunha, F. de Q., et al. (2013). Inflammatory intestinal damage induced by 5-fluorouracil requires IL-4. Cytokine, 61( 1), 46-49. doi:10.1016/j.cyto.2012.10.003
NLM
Soares PMG, Mota JMSC, Souza EP, Justino PFC, Franco AX, Cunha F de Q, Ribeiro RA, Souza MHLP. Inflammatory intestinal damage induced by 5-fluorouracil requires IL-4 [Internet]. Cytokine. 2013 ; 61( 1): 46-49.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.cyto.2012.10.003
Vancouver
Soares PMG, Mota JMSC, Souza EP, Justino PFC, Franco AX, Cunha F de Q, Ribeiro RA, Souza MHLP. Inflammatory intestinal damage induced by 5-fluorouracil requires IL-4 [Internet]. Cytokine. 2013 ; 61( 1): 46-49.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.cyto.2012.10.003
Artigo de periodico
Role of pratelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice (2011)
Soares, Pedro Marcos G.; Lima Junior, Roberto César P.; Mota, José Maurício S. C.; Justino, Priscilla F. C.; Brito, Gerly Anne C.; Ribeiro, Ronaldo de Albuquerque; Cunha, Fernando de Queiroz; Souza, Marcellus Henrique Loiola Ponte de
Source: Cancer Chemotherapy and Pharmacology. Unidade: FMRP
Subjects: CITOCINAS, SISTEMA GASTROINTESTINAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOARES, Pedro Marcos G. et al. Role of pratelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice. Cancer Chemotherapy and Pharmacology, v. 68, n. 3, p. 713-720, 2011Tradução . . Disponível em: https://doi.org/10.1007/s00280-010-1540-5. Acesso em: 01 nov. 2024.
APA
Soares, P. M. G., Lima Junior, R. C. P., Mota, J. M. S. C., Justino, P. F. C., Brito, G. A. C., Ribeiro, R. de A., et al. (2011). Role of pratelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice. Cancer Chemotherapy and Pharmacology, 68( 3), 713-720. doi:10.1007/s00280-010-1540-5
NLM
Soares PMG, Lima Junior RCP, Mota JMSC, Justino PFC, Brito GAC, Ribeiro R de A, Cunha F de Q, Souza MHLP de. Role of pratelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice [Internet]. Cancer Chemotherapy and Pharmacology. 2011 ; 68( 3): 713-720.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1007/s00280-010-1540-5
Vancouver
Soares PMG, Lima Junior RCP, Mota JMSC, Justino PFC, Brito GAC, Ribeiro R de A, Cunha F de Q, Souza MHLP de. Role of pratelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice [Internet]. Cancer Chemotherapy and Pharmacology. 2011 ; 68( 3): 713-720.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1007/s00280-010-1540-5
Artigo de periodico
Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution (2008)
Soares, Pedro M. G.; Mota, José Maurício S. C.; Gomes, Antoniella S.; Oliveira, Ricardo Brandt de; Assreuy, Ana Maria S.; Brito, Gerly Anne C.; Santos, Armênio A.; Ribeiro, Ronaldo de Albuquerque; Souza, Marcellus Henrique Loiola Ponte de
Source: Cancer Chemotherapy and Pharmacology. Unidade: FMRP
Subjects: MOTILIDADE GASTROINSTESTINAL, ESVAZIAMENTO GÁSTRICO, MÚSCULO LISO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOARES, Pedro M. G. et al. Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution. Cancer Chemotherapy and Pharmacology, v. 63, n. 1, p. 91-98, 2008Tradução . . Disponível em: https://doi.org/10.1007/s00280-008-0715-9. Acesso em: 01 nov. 2024.
APA
Soares, P. M. G., Mota, J. M. S. C., Gomes, A. S., Oliveira, R. B. de, Assreuy, A. M. S., Brito, G. A. C., et al. (2008). Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution. Cancer Chemotherapy and Pharmacology, 63( 1), 91-98. doi:10.1007/s00280-008-0715-9
NLM
Soares PMG, Mota JMSC, Gomes AS, Oliveira RB de, Assreuy AMS, Brito GAC, Santos AA, Ribeiro R de A, Souza MHLP de. Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution [Internet]. Cancer Chemotherapy and Pharmacology. 2008 ; 63( 1): 91-98.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1007/s00280-008-0715-9
Vancouver
Soares PMG, Mota JMSC, Gomes AS, Oliveira RB de, Assreuy AMS, Brito GAC, Santos AA, Ribeiro R de A, Souza MHLP de. Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution [Internet]. Cancer Chemotherapy and Pharmacology. 2008 ; 63( 1): 91-98.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1007/s00280-008-0715-9
Artigo de periodico
Amifostine (Wr-2721) prevents indomethacin-induced gastric damage in rats: role of non-protein sulfhydryl groups and leukocyte adherence (2007)
Mota, José Maurício S. C.; Soares, Pedro M. G.; Menezes, Álvaro A. J.; Lemos, Henrique P.; Cunha, Fernando de Queiroz; Brito, Gerly Anne C.; Ribeiro, Ronaldo A.; Souza, Marcellus H. L. P. de
Source: Digestive Diseases and Sciences. Unidade: FMRP
Assunto: GASTROENTEROPATIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOTA, José Maurício S. C. et al. Amifostine (Wr-2721) prevents indomethacin-induced gastric damage in rats: role of non-protein sulfhydryl groups and leukocyte adherence. Digestive Diseases and Sciences, v. 52, n. 1, p. 119-125, 2007Tradução . . Acesso em: 01 nov. 2024.
APA
Mota, J. M. S. C., Soares, P. M. G., Menezes, Á. A. J., Lemos, H. P., Cunha, F. de Q., Brito, G. A. C., et al. (2007). Amifostine (Wr-2721) prevents indomethacin-induced gastric damage in rats: role of non-protein sulfhydryl groups and leukocyte adherence. Digestive Diseases and Sciences, 52( 1), 119-125.
NLM
Mota JMSC, Soares PMG, Menezes ÁAJ, Lemos HP, Cunha F de Q, Brito GAC, Ribeiro RA, Souza MHLP de. Amifostine (Wr-2721) prevents indomethacin-induced gastric damage in rats: role of non-protein sulfhydryl groups and leukocyte adherence. Digestive Diseases and Sciences. 2007 ; 52( 1): 119-125.[citado 2024 nov. 01 ]
Vancouver
Mota JMSC, Soares PMG, Menezes ÁAJ, Lemos HP, Cunha F de Q, Brito GAC, Ribeiro RA, Souza MHLP de. Amifostine (Wr-2721) prevents indomethacin-induced gastric damage in rats: role of non-protein sulfhydryl groups and leukocyte adherence. Digestive Diseases and Sciences. 2007 ; 52( 1): 119-125.[citado 2024 nov. 01 ]

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em